Mankind Pharma Limited (BOM:543904)

Market Cap	893.02B -13.5%
Revenue (ttm)	139.14B +19.5%
Net Income	17.79B -12.8%
EPS	43.10 -15.2%
Shares Out	n/a
PE Ratio	50.19
Forward PE	38.33
Dividend	1.00 (0.05%)
Ex-Dividend Date	Aug 8, 2025

Volume	29,131
Average Volume	18,860
Open	2,125.00
Previous Close	2,186.45
Day's Range	2,107.35 - 2,170.75
52-Week Range	2,014.85 - 2,726.75
Beta	n/a
RSI	54.93
Earnings Date	May 22, 2026

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory diseases, etc. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, oral contraceptives, antacid powders, vitamin a...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 19,620
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543904

Financial Performance

In fiscal year 2025, Mankind Pharma's revenue was 122.07 billion, an increase of 18.98% compared to the previous year's 102.60 billion. Earnings were 19.91 billion, an increase of 4.08%.